Facebook Linkedin Twitter
Inside Precision Medicine Rebuilding Eye Disease Gene Therapy Pipeline, Biogen Buys Nightstar for $877M

Gene therapy (Therapeutics)

Rebuilding Eye Disease Gene Therapy Pipeline, Biogen Buys Nightstar for $877M
News & Features

Rebuilding Eye Disease Gene Therapy Pipeline, Biogen Buys Nightstar for $877M

0
Expanding into Gene Therapy, Roche Plans $4.8B Acquisition of Spark Therapeutics
News & Features

Expanding into Gene Therapy, Roche Plans $4.8B Acquisition of Spark Therapeutics

0
Genome Editing Tool Could be Key to Mitochondrial Disease Treatment
News & Features

Genome Editing Tool Could be Key to Mitochondrial Disease Treatment

0
Business Team Partnership Greeting Handshake Concept
News & Features

Precision BioSciences, UPenn to Collaborate on Genome Editing Therapeutics Development

0
Genetic engineering, GMO and Gene manipulation concept. Hand is inserting sequence of DNA.
News & Features

Gene Deletion May Aid Stroke, Spinal Injury Recovery

0
The FDA’s embrace of precision oncology
News & Features

ASCO Care Advances Report Highlights CAR-T Approvals, Other Clinical Progress Against Cancer

0
Caris Life Sciences has identified a new mechanism of action for an aptamer with potential to treat non-Hodgkin lymphoma (NHL)
Molecular Dx

Caris IDs Mechanism of Aptamer with Potential for Treating Non-Hodgkin Lymphoma

0
Synpromics
News & Features

Synpromics Grows with Its Synthetic Promoter Technology

0
Source: herbap/Getty Images
News & Features

U.S. Researchers Correct Germline Mutation in Human Embryos via CRISPR

0
Source: © kentoh - Fotolia.com
News & Features

Integrating Clinical Genomics Data into Standard Medical Practice

John Sterling
0
1...151617Page 17 of 17

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine